. Author manuscript; available in PMC: 2021 Apr 1.

Published in final edited form as: Ann Surg Oncol. 2019 Dec 17;27(4):1180–1188. doi: 10.1245/s10434-019-08099-9

Table 3.

Multivariate Analysis of Factors Associated with Overall Survival in the 237 Patients With Advanced Melanoma.

Clinical Factors	Hazard Ratio	95% Confidence Interval	p-value
Complete Resection to NED (No vs Yes)	2.75	1.44-5.25	.002
Pre-Operative Neutrophil to Lymphocyte Ratio (NLR) (continuous)	1.04	1.01-1.08	.024
Response to Checkpoint Blockade
Multiple Progressors vs Responding/Stable Disease	7.57	1.02-56.01	<.001
Isolated Progressor vs Responding/Stable Disease	3.05	0.42-22.36

NED, no evidence of disease.